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The storage and use of newborn babies’ blood 
spot cards: a public consultation 
 
Summary 
 
This consultation aims to gather the public’s views on the storage, use and management of 
the UK collections of newborn babies’ blood spot cards.  
 
First, this document explains the background to the storage of newborn blood spot cards, 
outlines the potential for research and other uses and explains the current management 
arrangements for the UK collections of these cards (see Section 1). Second, it provides 
information about the different uses, and asks for your views about these uses (see Section 
2). Third, it outlines the current structures for managing the collections of blood spot cards to 
serve the interests of the public and keep personal information private (see Section 3). 
 
 
 
1.0 Introduction 
1.1 What is the UK collection of newborn screening blood spot cards? 
 
In the UK, newborn babies are screened for a small number of rare but serious conditions, 
including phenylketonuria (PKU), congenital hypothyroidism (CHT), sickle cell disorders, and 
cystic fibrosis (CF). When babies are about a week old blood spots are collected from their 
heel onto blood spot cards (see below) and used for testing. Also included on these cards is 
basic information about the baby, such as the baby’s name, date of birth, contact details and 
NHS number. 
 
 
Newborn blood spot card (this picture is about half the size of the real cards) 
 
 
 
 
The aim of newborn blood spot screening is to prevent serious disability and even death, 
through early identification and treatment of these conditions. More information about the 
screening programme can be found at www.newbornscreening-bloodspot.org.uk/ 
 
Newborn blood spot screening began in the late 1960s and in some areas blood spot cards 
have been stored since then. In 2004 following a widespread public consultation, the UK 
Newborn Screening Programme Centre recommended that blood spot cards should be 
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stored routinely by newborn screening laboratories for at least 5 years to be available for 
checking the quality of the screening programme for which they were initially collected.  
 
In addition to checking the quality of the screening programme, there are a number of 
reasons for storing blood spot cards. These reasons may justify keeping the blood spot 
cards for more than 5 years. 
 
Although these blood spot cards are stored in several laboratories around the country, they 
are stored for the same purposes and are regulated in the same ways. For this reason we 
consider these collections together and call them the UK newborn blood spot bank. 
 
Your views will guide the future storage and use of newborn blood spot cards. 
 
 
 
1.2 What are the potential uses of the blood spot cards? 
 
Blood spot cards contain four small dried blood spots and some basic information for each 
baby. Once newborn screening is completed, these cards are stored and can be used in a 
number of ways, each of which is described in more detail in Section 2.  
 
These potential uses include those linked directly to the screening programme, and other 
uses that are made possible because these blood spot cards have been stored after 
screening. This blood spot bank is unique because the spots are collected from almost all 
babies born in the UK when they are about a week old. This makes them particularly useful 
for health research relevant to mothers and children. 
 
The blood spot cards can be used after screening to check the result of the original test; to 
improve the screening programme; to help families identify why a child has died; for other 
tests recommended by the family’s doctor; for research to develop new equipment or tests 
for public health monitoring; or for research to help improve the health of babies and their 
families in the UK. 
 
 
1.3 What are the current arrangements to protect the interests of the public and keep 
personal information private?  
¾ Parents give informed consent for their babies to be screened 
 
All parents are offered newborn blood spot screening for their babies. A national leaflet is 
given to all parents. It can be accessed from www.newbornscreening-bloodspot.org.uk/  
 
This leaflet contains the following wording:  
 
 
What happens to your baby’s blood spots after screening? 
 
After screening, newborn blood spots are stored for at least 5 years and may be used in a 
number of ways: 
¾ To check the result or for other tests recommended by your doctor 
¾ To improve the screening programme 
¾ For research to help improve the health of babies and their families in the UK. This 
research will not identify your baby, and you will not be contacted.  
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The use of these blood spots is governed by a Code of Practice, available from your midwife 
or via www.newbornscreening-bloodspot.org.uk 
 
In the future there is a small chance researchers may want to invite you or your child to 
take part in research linked to the blood spot programme. If you do not wish to receive 
invitations to take part in research please let your midwife know.  
 
 
¾ Storage of blood spot cards is regulated 
 
Newborn screening laboratories are responsible for testing newborn blood spots for the 
screening programme. The laboratory directors become ‘custodians’ of the blood spot cards, 
storing them, and ensuring guidelines about their storage and use are followed. There is 
strict guidance about who is allowed to access these blood spot cards and how the cards 
can be used.  
 
¾ Use of blood spot cards is regulated 
 
Laws cover the use of the blood spot cards, in particular the Human Tissue Act 2004, the 
Data Protection Act 1998, and the Health and Social Care Act 2001. The specific guidance 
relating to the management of the blood spot bank has been developed with careful 
reference to these laws. These Acts are not described in detail here, but further information 
can be accessed via the Office of Public Sector Information at www.opsi.gov.uk/legislation/    
 
In 2004 the UK Newborn Screening Programme Centre consulted parents and health 
professionals about the screening programme and stored blood spot cards. Taking into 
account their views, the Centre developed guidance for laboratory directors on the storage, 
use and release of blood spot cards. This guidance can be found in ‘The Code of Practice 
for the Retention and Storage of Residual Spots’ available from  
www.newbornscreening-bloodspot.org.uk/  
 
One of the requirements of both the Code of Practice and the Human Tissue Act described 
above is: blood spot cards can only be used in research projects if they have approval from 
a committee that considers the ethics of the research (a Research Ethics Committee).  More 
information about research ethics committees is available from the Central Office for 
Research Ethics Committees at www.corec.org.uk/  
 
The Code of Practice also requires that only research that makes good use of blood spot 
cards by addressing important questions with high quality methods can be allowed to use 
blood spots. All potential research projects must therefore be reviewed by other scientists 
before they can be approved. This process is known as ‘scientific peer review’.   
 
Practical procedures (often called Standard Operating Procedures) are currently being 
developed by newborn screening laboratories, in consultation with the UK Newborn 
Screening Programme Centre. These procedures will ensure that both the blood and the 
information stored on the blood spots cards are stored securely and can only be accessed 
by authorised members of staff.  
 
The UK Newborn Screening Programme Centre also provides advice to newborn screening 
laboratories about the use of blood spot cards, and will record the use of the blood spot 
cards as part of an annual report.  
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Steps are taken to keep private any personal information contained in, or linked in any way 
to, the UK newborn blood spot bank. This is done in different ways, depending on what the 
spots are used for, and is guided by the Code of Practice and Research Ethics Committees 
described above. Individuals’ identities are protected by removing identifying information 
from the blood spots before they can be used. 
 
 
1.4 What does this consultation ask and what will happen to the findings? 
 
This consultation asks about:  
 
1. Public attitudes to the various uses of stored blood spot cards.  
2. Public attitudes about how the UK newborn blood spot bank is managed to serve the 
interests of the public and keep personal information private 
 
The consultation is guided by an advisory group of experts with backgrounds in public 
health, ethics, law, genetics, laboratory science and patient involvement in research and 
health policy. This group advises on how the consultation should be conducted.  
 
The consultation is conducted by a research team with experience of public health, 
laboratory science, social science and public involvement in research and health policy 
(listed at the front of this document).  
 
We are gathering public attitudes from:  
• a web-based consultation in Autumn 2005 (this document) 
• interviews and focus groups with members of the public in Autumn 2005 
• a working group made up of members of the public which will meet in Spring 2006. 
This group will discuss in depth how blood spots can be used and public attitudes to 
this. The group will help draft a report of the public’s views on the uses and 
management of the UK newborn blood spot card bank.  
 
This report will be considered by the consultation’s advisory group. Taking into account the 
views of the public, as well as information about the costs and practical requirements of 
storage, this advisory group will make recommendations to researchers, policy-makers and 
practitioners about what the UK newborn blood spot bank should be used for and how it 
should be managed. 
 
 
 
          
 
7
2.0 Uses of the UK newborn blood spot bank  
 
Here we ask you to tell us your views about what the blood spot cards are used for. We shall 
ask you later to share your views on how the UK newborn blood spot bank is managed to 
serve the interests of the public and keep personal information private (see Section 3).  
 
2.1 Blood spot cards are used to monitor and improve the screening programme  
 
The UK Newborn Screening Programme Centre standards for newborn blood spot screening 
require all blood spot cards to be stored for at least 5 years to maintain the high quality of the 
screening programme.  
 
Newborn screening laboratories and the UK Newborn Screening Programme Centre use 
information from existing blood spot cards to monitor and improve the screening programme. 
They use the blood spots to double check the accuracy of the screening tests they are using. 
For example they may retest a number of blood spots from time to time to confirm result. 
 
The laboratory may also use stored blood spots to develop and check new methods of 
testing for conditions for which screening is currently offered.  Stored blood spots might also 
be used to develop tests for different conditions for which screening might be offered in 
future. 
 
Using blood spots to monitor and improve screening is essential for the screening 
programme. If blood spots could not be used for these purposes the newborn blood spot 
screening programme would provide a poorer service to parents. It would not be so 
successful in saving lives and preventing severe disability from a few rare but serious 
conditions. Nor could it make improvements as new tests and new technologies are 
developed.  
 
Using blood spots to develop tests for different conditions, which might be included in routine 
screening in the future, may raise concerns about whether families will be contacted with 
results they were not expecting. This problem is prevented by testing blood spots only after 
they have been separated from information identifying individuals, so the testing is done 
anonymously.   
 
 
 
 
Q1a. Please consider the following statement and tick one of the 5 options below: 
 
It is appropriate that blood spot cards can be used by laboratories as described above to 
monitor and improve the screening programme. 
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer:  
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Q1b. Do you have other comments about the use of blood spot cards to monitor and 
improve the screening programme? 
 
 
 
 
 
 
 
 
2.2 Blood spot cards are used to directly benefit individuals and families  
 
Stored blood spot cards may be used for the direct benefit of the family or child. For example 
if a baby has died but the cause is unclear, at a doctor’s request, the baby’s blood spot card 
can be tested after an interval of many years to try to identify the cause.  This may provide 
valuable information for parents about the cause of death, and can provide families with 
information about their risk of having another baby with that condition.  
 
Blood spots might also be tested to try to identify the body of someone who has been killed 
in a disaster when there is no other way to identify them. For example, newborn blood spot 
cards have been used to identify bodies of people killed in a factory fire and those killed in 
the tsunami on Boxing Day 2004.  
 
These uses of the blood spot cards are uncommon but are of direct benefit to individuals or 
their families. When they are used to help in situations such as those described above, this 
can be of enormous value to the family involved. A few families may benefit from these uses 
in the first 5 years, when the spots are stored for the screening programme. However, if 
blood spot cards are stored for longer, these benefits will continue to be possible over a 
longer period. 
 
 
 
Q2a: Please consider the following statement and tick one of the 5 options below: 
 
It is appropriate that stored blood spot cards be used for the benefit of individuals and their 
families.  
   
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer: 
 
Q2b: Please consider the following statement and tick one of the 5 options below: 
 
Blood spot cards should be stored for more than 5 years for uses that directly benefit 
families.  
   
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
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5. Strongly disagree 
 
Please give your reasons for your answer: 
 
 
Q2c. Do you have other comments about the use of blood spot cards for individuals and 
their families? 
 
 
 
 2.3 Blood spot cards are used to monitor health in the general population  
 
Blood spot cards can be used as part of public health monitoring, to answer questions about 
the health of the general population, to inform health service planning and to monitor how 
well public health policies prevent or manage disease. The blood spots are particularly 
valuable because it is possible to find out information about mothers health from their babies 
blood spots.  
 
Care is always taken to keep personal information private when blood spot cards are used in 
this way. Identifying information is removed from the blood spots so they are anonymised. 
 
For example, 15 years ago we were unsure how widespread HIV infection was in the UK 
and whether it was becoming more common. By testing the stored blood spots of newborn 
babies anonymously so it was impossible to identify individuals and their results, it was 
shown that the number of HIV-infected pregnant women was steadily increasing. This 
information led directly to the introduction of a national policy to recommend voluntary HIV 
testing to all pregnant women in 1999.  Advances in methods to prevent a mother 
transmitting HIV infection to her child has reduced the risk of a baby being infected from 1 in 
5 to less than 1 in 50, and now almost 90% of pregnant women accept voluntary testing for 
HIV.  At the same time anonymous HIV testing of stored blood spots is continuing so that the 
effectiveness of the voluntary screening programme can be monitored. 
 
The value of stored blood spot cards for monitoring health in the general population is 
increased enormously if blood spot cards can be stored beyond the initial 5 years required 
by the screening programme. 
 
 
Q3a. Please consider the following statement and tick one of the 5 options below: 
 
It is appropriate that blood spot cards can be used to monitor health in the general 
population. 
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer:  
 
 
Q3b. Do you have comments about the storage of blood spot cards, beyond the 5 years 
required by the screening programme, for monitoring health in the general population? 
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2.4 Blood spot cards are used to answer questions about health problems  
 
Researchers can use blood spot cards to answer questions about specific health problems.  
 
For example, researchers exploring the reasons why a child develops leukaemia have used 
the blood spots of individuals who have developed the condition in later childhood, to see if 
the condition was present when these children were a week old.  
 
Researchers have also used anonymised blood spots to identify how common certain 
infections are among pregnant women, including rubella and other viruses such as Hepatitis 
B Virus (HBV) and Hepatitis C Virus (HCV). The advantage of using the blood spot bank to 
do this, is that cards are available for almost all babies, and these questions can therefore 
be answered quickly and cheaply. 
 
Researchers have also used blood spots to test for viral infections in children and to try and 
answer questions about how these infections affect children’s long-term health.  For 
example, researchers have used blood spots to explore links between infections and 
conditions such as leukaemia. Some research has been carried out to test stored blood 
spots for environmental and chemical exposures, such as pesticides. 
 
Stored blood spot cards have also been used to investigate genetic conditions. For example, 
researchers have used anonymised blood spots to look for links between Sudden Infant 
Death Syndrome (SIDS or ‘cot death’) and specific genetic variations. Other studies have 
used blood spots from a large section of the population to try and identify any genetic causes 
of conditions such as cerebral palsy, childhood leukaemia, and other cancers.  
 
Research using blood spot cards, particularly genetic research, may result in the type of 
information about individuals that insurance companies would be interested in. However, 
access to this information by insurance companies is not currently permitted in the UK.  
 
The value of stored blood spot cards for research about health increases considerably if 
blood spot cards are stored beyond the initial 5 years required by the screening programme. 
 
Q4a. Please consider the following statement and tick one of the 5 options below:  
 
It is appropriate that blood spot cards can be used to answer questions about health 
problems. 
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer:  
 
 
 
 
Q4b: Do you have other comments about the storage of blood spot cards, beyond the 5 
years required by the screening programme, for research to answer questions about health 
problems? 
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2.5  Blood spot cards are used to develop equipment and tests  
 
Blood spot cards can be used to develop new equipment and tests, which may make it 
possible to identify more conditions early, when babies are just a few weeks old, leading to 
early treatment and preventing serious disability in later life.  
 
For example, newborn blood spot cards have been used to develop equipment called a 
tandem mass spectrometer. This allows tests to be carried out on very small amounts of 
blood.  
 
The development of new health care equipment and tests relies heavily on the biomedical 
industry. Commercial organisations working with newborn screening laboratories may wish 
to use blood spot cards directly to ensure new equipment meets required standards. In 
addition researchers may wish to do research funded by commercial organisations using the 
blood spot cards. University researchers and commercial organisations increasingly work 
alongside one another. This means is can be difficult to distinguish between research by 
university researchers and research by industry.  
 
In the future commercial organisations may be interested in accessing whole collections of 
blood spots. This has not occurred in relation to newborn blood spot cards, although it has 
happened with other adult blood samples, for example the DeCode project in Iceland [see 
www.decode.com/ for more information].  
 
 
Like other uses of the UK newborn blood spot bank, commercial uses of the blood spot 
cards are strictly regulated (see Section 3 for more information). 
 
Use of the blood spot cards by commercial organisations raises the issue of who owns the 
knowledge gained. This issue is particularly important where there are financial implications 
from the findings, either for the researchers, or for the company which funds the research.  
 
 
 
Q5a. Please consider the following statement and tick one of the 5 options below: 
 
It is appropriate that blood spot cards are stored, beyond the 5 years required by the 
screening programme, to develop equipment and tests.  
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer:  
 
 
 
Q5b. Do you have any comments about commercial companies using blood spot cards to 
develop equipment or tests? 
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2.6  Blood spot cards are used with additional ‘linked’ information 
 
Public health monitoring (2.3 above) and research (2.4 and 2.5 above) about health 
conditions using newborn blood spot cards are often most beneficial if the blood spot cards 
can be linked to additional information. As explained below, steps are taken to ensure that 
personal information is protected and that the identity of individuals is not revealed. 
 
More information about the use of personal information in medical research is available from 
www.mrc.ac.uk/pdf-pimr.pdf/ 
 
Additional information about individuals is available via the Office of National Statistics, for 
example, information may be obtained from birth registration records. Additional information 
about individuals is also available through the NHS Hospital Episode System. This system 
includes data about when people attend hospital, for example, information that a child has 
been admitted to hospital for a sickle cell disorder or diabetes. 
 
If blood spot cards can be linked to these different types of additional information it allows 
researchers to relate the results of tests done on the stored blood spots to subsequent 
health status. It is also possible to select blood spots from children with and without specific 
diseases and to test them for different infections or genetic markers. For example, 
researchers can explore whether certain genetic variations might predict diabetes.  
 
Researchers recognise the importance of keeping personal information private and take 
steps to do this. Studies that link blood spots to additional information do not identify 
individuals.  
 
Linking additional information to the blood spots in these ways is strictly controlled. More 
explanation and an opportunity to comment on these arrangements are provided in    
Section 3.  
 
Q6a. Please consider the following statement and tick one of the 5 options below: 
 
It is appropriate that blood spots can be linked to additional information for research or public 
health monitoring 
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer:  
 
 
 
Q6b. Do you have any other comments about the linking of additional information to the 
blood spots? If yes, please specify exactly what you are concerned about and why. 
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2.7  Blood spot cards are used for forensic police work  
 
Police may access the blood spot cards of specific deceased or missing persons for forensic 
purposes only if they first obtain a court order. This is extremely unusual. 
 
Police may want to use a blood spot card to identify the body of someone who has been 
killed in a disaster when there is no other way to identify them. For example blood spot cards 
were used to identify some of the victims of the Boxing Day 2004 tsunami. 
 
Current guidance set out in the Code of Practice (see section 3.1) is that samples from 
individuals who are alive and not missing would not be released without a court order for this 
purpose since alternatives are available. 
 
The use of blood spot cards to help solve crimes raises the issue of whether police should 
be able to test a large number of spots in the hope of identifying a criminal. The courts do 
not currently permit this. Although police keep their own database of blood spots acquired 
from suspected criminals for such purposes, this is not related in anyway to the stored 
newborn blood spots cards. Testing large numbers of blood spot cards to identify a criminal 
is not allowed.  
 
Storing blood spot cards beyond the initial 5 years required by the screening programme, 
extends the potential for the blood spot cards to help with forensic police work. 
 
Q7a. Please consider the following statement and tick one of the 5 options below: 
 
It is appropriate for stored blood spot cards to be used to help with forensic police work with 
a court order. 
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
 
Q7b: Do you have other comments about the storage of blood spot cards beyond the initial 5 
years required by the screening programme, to help with forensic police work?  
 
 
2.8  Balancing the uses of blood spots 
 
To summarise, newborn blood spots have valuable uses for individuals, families and the 
population as a whole. Currently only four blood spots are collected for screening. Blood 
spots from very few individuals are used for reasons other than screening or anonymous HIV 
testing. The likelihood of needing to use blood spots after screening for individuals or their 
families is also very, very low. On the very rare occasions that they are used to directly 
benefit individuals or their families, the information from test results is very valuable.  
 
This raises the issue about whether blood spots from an individual should only be used for 
research or public health monitoring if there is enough blood left afterwards for the family. In 
other words, should some blood always be kept in case it might be needed for the direct 
benefit of that individual or their family in the future? 
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Q8a: Please consider the following statement and tick one of the 5 options below: 
 
If blood spots are requested for research or public health monitoring, the request should be 
refused if it would use up all the remaining blood (ie leave insufficient blood for tests which 
may directly benefit the individual or their family in the future.) 
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer: 
 
Q8b. Do you have other comments about keeping some blood especially for uses that 
directly benefit the family?  
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3.0 Overseeing the storage and use of the UK newborn blood spot 
bank 
 
This section explains in more detail, how blood spots are collected for newborn blood spot 
screening, and the current arrangements for how storage and use of blood spot cards is 
regulated.  
 
We would like to know your views on these current arrangements.  
 
3.1 Current arrangements managing the UK newborn blood spot bank 
 
As outlined in Section 2, there are a number of ways in which the storage and use of the 
newborn blood spot bank are managed: 
¾ Parents give informed consent for their babies to be screened 
 
When parents are offered newborn blood spot screening for their baby, they are provided 
with a pre-screening leaflet enabling them to make an informed choice about screening.   
 
As outlined in Section 1, this leaflet contains the following wording:  
 
 
What happens to your baby’s blood spots after screening? 
 
After screening, newborn blood spots are stored for at least 5 years and may be used in a 
number of ways: 
¾ To check the result or for other tests recommended by your doctor 
¾ To improve the screening programme 
¾ For research to help improve the health of babies and their families in the UK. This 
research will not identify your baby, and you will not be contacted.  
 
The use of these blood spots is governed by a Code of Practice, available from your midwife 
or via www.newbornscreening-bloodspot.org.uk 
 
In the future there is a small chance researchers may want to invite you or your child to 
take part in research linked to the blood spot programme. If you do not wish to receive 
invitations to take part in research please let your midwife know.  
 
 
 
¾ Storage of blood spot cards is regulated 
 
Laboratories test the blood spots for the conditions within the blood spot screening 
programme. More information about this programme can be accessed at 
www.newbornscreening-bloodspot.org.uk/ 
 
The blood spot cards are stored for 5 years for the direct purpose of the screening 
programme. Blood spot cards are stored beyond this initial 5 years for a number of potential 
uses, discussed in detail in Section 2.  
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As outlined in Section 1, the laboratory directors are ‘custodians’ of the blood spot cards, 
storing them, and ensuring guidelines about their use are followed. There is strict guidance 
about who is allowed to access these blood spot cards and how the cards can be used.  
 
¾ Use of blood spot cards is regulated 
 
As described in Section 1, the management of the storage and use of the blood spot cards is 
guided by laws, a code of practice and standard practical procedures. 
 
Laws cover the use of the blood spot cards, in particular the Human Tissue Act 2004, the 
Data Protection Act 1998, and the Health and Social Care Act 2001. The specific guidance 
relating to the management of the blood spot bank has been developed with careful 
reference to these laws. These Acts are not described in detail here, but further information 
can be accessed via the Office of Public Sector Information at www.opsi.gov.uk/legislation/    
 
In 2004 the UK Newborn Screening Programme Centre consulted parents and health 
professionals about the screening programme and stored blood spot cards. Taking into 
account their views, the Centre developed guidance for laboratory directors on the storage, 
use and release of blood spot cards. The guidance can be found in ‘The Code of Practice for 
the Retention and Storage of Residual Spots’ available from  
www.newbornscreening-bloodspot.org.uk/  
 
One of the requirements of both the Code of Practice and the Human Tissue Act described 
above is: blood spot cards can only be used in research projects if they have approval from 
a committee that considers the ethics of the research (a Research Ethics Committee).  More 
information about research ethics committees is available from the Central Office for 
Research Ethics Committees at www.corec.org.uk/  
 
The Code of Practice also requires that research must make good use of blood spot cards 
by addressing important questions with high quality methods. All potential research projects 
must therefore be reviewed by other scientists before they can be approved. This process is 
known as ‘scientific peer review’.   
 
Practical procedures (often called Standard Operating Procedures) are currently being 
developed by newborn screening laboratories, in consultation with the UK Newborn 
Screening Programme Centre. These procedures will ensure that both the blood and the 
information stored on the blood spots cards are stored securely and can only be accessed 
by authorised members of staff.  
 
The UK Newborn Screening Programme Centre also provides advice to newborn screening 
laboratories about the use of blood spot cards, and will record the use of the blood spot 
cards as part of an annual report.  
 
Steps are taken to keep private any personal information contained in, or linked in any way 
to, the UK newborn blood spot bank. This is done in different ways, depending on what the 
spots are used for, and is guided by the Code of Practice and Research Ethics Committees 
described above. Individuals’ identities are protected by removing identifying information 
from the blood spots before they can be used. 
 
 
3.2 Public involvement in managing the UK newborn blood spot bank 
 
The public are currently represented in the management arrangements for the UK newborn 
blood spot bank in a number of ways. These have included:  
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o public input into a 2004 consultation about the UK Newborn Screening Programme 
Centre’s Code of Practice;  
o public input into the laws that relate to this UK newborn blood spot bank;  
o ongoing public involvement through members of the public who routinely sit on 
research ethics committees. 
 
We suggest two more ways for involving the public in the management of the UK newborn 
blood spot bank.  
 
 
¾ A public scrutiny panel  
 
This panel would consist of around ten members of the public with access to additional 
scientific advisors and administrative support.   
 
At the end of each year, this panel would receive a report from the UK Newborn Screening 
Programme Centre of the individual, public health monitoring and research uses of the 
stored blood spot cards. It would then issue guidance to the UK Newborn Screening 
Programme Centre and to the laboratory directors about these uses, raise any areas of 
concern, and identify opportunities for improvement. This panel would also be available to 
advise on the potential use of the blood spot cards should any controversial issues arise that 
are not resolved by the procedures outlined in the Human Tissue Act and the Code of 
Practice.  
 
A public panel such as this would need support and funding. Existing public panels may be 
able to take on this role, for example those set up within the NHS to advise on health care 
planning or research.  
 
 
¾ A 5-yearly public consultation exercise 
 
This 5-yearly public consultation could invite members of the public to comment on the uses 
and management of the UK newborn blood spot bank (in a similar way to this consultation).  
 
A 5-yearly public review such as this would need funding and a clear route for reporting its 
findings to ensure the public’s views were taken into account by those managing the UK 
newborn blood spot bank.  
 
 
Q9a: Do you agree that there is a need for ongoing public involvement in the management of 
the UK newborn blood spot bank? 
 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
 
Please give your reasons for your answer: 
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Q9b: Which of the proposed models do you think should be used?  
 
1. Neither the public panel nor the 5 yearly public consultations 
2. The public panel only 
3. The 5 yearly consultations only 
4. Both the public panel and the 5 yearly consultations 
 
Please give your reasons for your answer: 
 
 
 
Q9c: Do you have any other suggestions or comments about ongoing public involvement in 
the management of the stored blood spot cards? 
 
 
 
 
 
Thank you for answering our questions  
 
 
 
Q10: The questions above ask for your views on:  
  
 
• the benefits and challenges of research using stored newborn blood spot cards, and 
• the management of the UK newborn blood spot bank  
 
  
Are there any other questions that you feel are important for us to consider? 
If you have any other views about the storage, use or management of newborn blood 
spot cards please add them below.  
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Responding to the consultation 
 
Please submit response online at: http://eppi.ioe.ac.uk/questionnaire/ 
 
 
 
 
 
If we receive your response electronically, there is no need for you also to send a paper 
copy. If you should prefer to respond by post or by fax, you may send completed responses 
to:  
 
Blood Spot Public Consultation  
Social Science Research Unit 
Institute of Education, University of London 
18 Woburn Square 
London 
WC1H 0NR 
 
Fax: 0207 612 6400 
 
 
Additional copies of this document can be downloaded from our website: 
http://www.ioe.ac.uk/ssru/reports/publicconsultationbloodspots.pdf 
 
 
For printed copies, please contact us at the above address. 
 
Thank you. 
 
 
CLOSING DATE FOR RESPONSES: 6th January 2006 
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Details of respondents 
We would like to know more about you, to allow us to take into account the range of people 
responding to this consultation. All personal information will be stored securely and will only 
be accessed by the research team. We will only report your responses if you give us your 
permission to do so, and if you prefer us to only do this anonymously, we will adhere to your 
wishes. Please indicate your preferences below.  
 
 
 
Please complete and return with your responses by 6th January 2006 
 
Name:  
Organisation: 
Address: (optional)1 
 
 
 
 
Telephone:  
Email:  
 
 
Are you responding individually on your own behalf, or on behalf of your 
organisation? 
□ Individual  
□ Organisation 
 
Please tick which description(s) best describe you:  
A newborn screening provider: 
□ A health professional involved in screening, or their representative 
□ A national or international screening organisation 
 
A child, parent or other family member:  
□ A child or young person under the age of 18 unaffected by the screened 
conditions 
□ A child or young person under the age of 18 affected by the screened 
conditions 
□ A parent of a child unaffected by the screened conditions 
□ A parent of a child affected by one of the screened conditions 
□ A family member (other than a parent) of a child unaffected by the screened 
conditions 
                                                
1 Please note that if we do not have your address we will not be able to send you a copy of the 
report when it is published. 
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□ A family member (other than a parent) of a child affected by one of the 
screened conditions 
□ A member of a support group related to one of the screened conditions 
□ A member of a support group not related to the screened conditions 
□ A member of a genetic interest group 
 
 
A potential user of the UK newborn blood spot bank; 
□ A researcher  
□ A research funder 
□ A research organisation 
 
A member of ethical or moral structures within UK society  
□ A member of an organisation protecting consumer rights 
□ A member of an ethical or religious group 
 
 
Other member of the public:  
 
□ A member of the public with no particular involvement or links to newborn 
screening or the UK newborn blood spot bank 
□ Other (Please specify ……………………………………..) 
 
 
 
 
Please indicate your view regarding the following statements:  
 
 
This response may be published as part of an appendix to the final report  
□ Yes 
□ No  
□ Anonymously only 
 
This response may be quoted in the report 
□ Yes 
□ No  
□ Anonymously only 
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This response may be made available to other researchers interested in the topic 
□ Yes 
□ No  
□ Anonymously only 
 
 
If you have answered ‘yes’ to any of the above questions, please indicate your name 
and/or the title of your organisation, as it should appear in print:  
 
Name:  
 
Organisation:  
 
 
Please let us know where you heard about the consultation:  
 
□ Website 
□ Sent an invitation to respond 
□ Other (please state) 
 
 
We would like to be able to contact you again about this topic. May we keep your 
contact details for this purpose? We will only use these details as specified above 
and will not pass them to third parties without your specific permission.  
 
Yes, you may keep my contact details 
 
□ Only until the Report is published, so that you can send me a copy           
□ Until I notify you otherwise 
□ Please do not keep my contact details 
 
 
 
          
First produced in 2005 by: 
 
Social Science Research Unit 
Institute of Education, University of London 
18 Woburn Square 
London WC1H 0NR 
Tel: 020 7612 6397 
 
http://www.ioe.ac.uk/ssru/  
 
 
 
 
 
 
 
 
 
Founded in 1990, the Social Science Research Unit (SSRU) is based at the Institute of 
Education, University of London. Our mission is to engage in and otherwise promote 
rigorous, ethical and participative social research as well as to support evidence-informed 
public policy and practice across a range of domains including education, health and 
welfare, guided by a concern for human rights, social justice and the development of human 
potential. 
 
The views expressed in this work are those of the authors and do not necessarily reflect the 
views of the funder. All errors and omissions remain those of the authors. 
 
This report is available to download from:  
http://www.ioe.ac.uk/ssru/reports/publicconsultationbloodspots.pdf 
 
 
 
 
 
 
 
 
 
This document is available in a range of alternative formats.  
Please contact the Marketing and Development Office for assistance.  
 
Telephone 020 7947 9556 Email info@ioe.ac.uk  
 
 
 
 
 
 
